Literature DB >> 20386446

Prevention of parenteral nutrition-associated liver disease: lipid minimization.

M Petrea Cober1, Daniel H Teitelbaum.   

Abstract

PURPOSE OF REVIEW: The cause of parenteral nutrition-associated liver disease (PNALD) is unknown. Evidence over the past decade has suggested soybean oil-based intravenous emulsions are a contributing factor to the development of PNALD. RECENT
FINDINGS: This review details the historical and scientific rationale, which associates intravenous lipid emulsion administration and PNALD. The article then reviews our own group's experience with lipid restriction and the reversal of PNALD in neonates on long-term parenteral nutrition. Finally, a clinical approach to restricting soybean-based intravenous lipid emulsions in parenteral nutrition is given.
SUMMARY: An association between intravenous lipid emulsion administration and the development of PNALD seems probable. Strategies to reduce lipid emulsions or develop new, nonsoybean-based lipid emulsions should be considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386446     DOI: 10.1097/MOT.0b013e328338c2da

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  28 in total

1.  ESPEN guideline on clinical nutrition in liver disease.

Authors:  Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff
Journal:  Clin Nutr       Date:  2019-01-16       Impact factor: 7.324

2.  Intestinal Failure-Associated Liver Disease and Eicosapentaenoic Acid/Arachidonic Acid Ratio.

Authors:  Wataru Miura; Nobuhiko Nagano; Ryota Kato; Aya Okahashi; Kayo Yoshikawa; Kensuke Ohashi; Tsugumichi Koshinaga; Ichiro Morioka
Journal:  Indian J Pediatr       Date:  2019-02-13       Impact factor: 1.967

3.  Parenteral nutrition supplementation in biliary atresia patients listed for liver transplantation.

Authors:  Jillian S Sullivan; Shikha S Sundaram; Zhaoxing Pan; Ronald J Sokol
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

4.  Essential fatty acid deficiency during parenteral soybean oil lipid minimization.

Authors:  K D Ernst
Journal:  J Perinatol       Date:  2017-03-23       Impact factor: 2.521

Review 5.  Emerging Clinical Benefits of New-Generation Fat Emulsions in Preterm Neonates.

Authors:  Gregory Guthrie; Muralidhar Premkumar; Douglas G Burrin
Journal:  Nutr Clin Pract       Date:  2017-01-27       Impact factor: 3.080

6.  The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.

Authors:  Sabrina E Sanchez; Lindsay P Braun; Laina D Mercer; Meredith Sherrill; Jennifer Stevens; Patrick J Javid
Journal:  J Pediatr Surg       Date:  2013-03       Impact factor: 2.545

7.  Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease.

Authors:  Karim C El Kasmi; Aimee L Anderson; Michael W Devereaux; Padade M Vue; Wujuan Zhang; Kenneth D R Setchell; Saul J Karpen; Ronald J Sokol
Journal:  Sci Transl Med       Date:  2013-10-09       Impact factor: 17.956

8.  Impact of pediatric intestinal transplantation on intestinal failure in Japan: findings based on the Japanese intestinal transplant registry.

Authors:  Takehisa Ueno; Motoshi Wada; Ken Hoshino; Shinji Uemoto; Tomoaki Taguchi; Hiroyuki Furukawa; Masahiro Fukuzawa
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

9.  Prevention and treatment of intestinal failure-associated liver disease in children.

Authors:  Bram P Raphael; Christopher Duggan
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

Review 10.  Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.

Authors:  Vishal Kapoor; Rebecca Glover; Manoj N Malviya
Journal:  Cochrane Database Syst Rev       Date:  2015-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.